Junction, a diagnostic testing infrastructure platform, has announced a collaboration with GRAIL to support access to the Galleri multi-cancer early detection test across digital health platforms and clinical organisations. Through Junction's infrastructure, healthcare providers can integrate Galleri into their workflows with unified ordering, embedded physician networks and streamlined operational support. The Galleri test is a blood test designed to detect signals from over 50 cancer types, many lacking recommended screening options. Junction's platform enables organisations to order the Galleri test directly, support multi-state clinical operations and manage complex testing workflows. The collaboration aims to simplify the operational steps around offering Galleri, making it easier for providers to integrate the test into care delivery. Junction provides infrastructure that powers healthcare platforms through a single API.

Junction, formerly known as Vital, has raised $18M in a Series A funding round led by Creandum, with participation from Y Combinator and others. The funding will enhance healthcare infrastructure by improving data integration and patient care. Junction's platform offers nationwide lab test ordering, automated workflows, and connectivity with over 500 devices. The rebrand reflects its role as a connection point in healthcare systems. Junction supports over 140 organizations and processes 500k tests annually.